The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Regarding the article entitled “A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: Results of a randomised controlled trial”
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Trials using objective recorded measures suggest that adherence to inhaled therapies in people with CF is around 31% to 36% in adults.
“Trials using objective recorded measures suggest that adherence to inhaled therapies in people with CF is around 31% to 36% in adults (Daniels 2011;Hoo 2019;Hoo 2020;Hoo 2021)”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Hoo 2020
The Dear Editor section says adherence to preventative therapies in CF may be as low as 35–50%, supporting the general point that adherence can be low. It does not give the claimed 31–36% range or specify that the estimate comes from trials using objective recorded measures in adults receiving inhaled therapies. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pulmonary medication adherence and health-care use in cystic fibrosis
Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A. (2014) · Chest · doi:10.1378/chest.13-1926 · Cited by 250
Accurate Assessment of Adherence
Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D. (2011) · Chest · doi:10.1378/chest.09-3074 · Cited by 210
Lechtzin, N., Mayer-Hamblett, N., West, N. E., Allgood, S., Wilhelm, E., Khan, U., Aitken, M. L., Ramsey, B. W., Boyle, M. P., Mogayzel, P. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2172oc · Cited by 127
Flagged first, then by citations
Research works printed but not linked: 6
- Wood, 2019, A smartphone application for reporting symptoms in adults with cystic fibrosis improves the detection of exacerbations: results of a randomised controlled trial, J Cyst Fibros
- Bell, 2017, Early intervention of cystic fibrosis pulmonary exacerbations based on home monitoring. eICE through the looking glass, Am J Respir Crit Care Med, 196, 1090, 10.1164/rccm.201706-1207ED · DOI
- Wood, 2018, A smartphone application for reporting symptoms in adults with cystic fibrosis: protocol of a randomised controlled trial, BMJ Open, 8, 10.1136/bmjopen-2017-021136 · DOI
- Somayaji, 2017, Lung function recovery in cystic fibrosis following a pulmonary exacerbation treated with intravenous and oral antibiotics: analysis of the eICE trial, Pediatr Pulmonol, 52, S383
- Hoo, 2019, Intravenous antibiotic use and exacerbation events in an adult cystic fibrosis centre: A prospective observational study, Respir Med, 154, 109, 10.1016/j.rmed.2019.06.017 · DOI
- Edmondson, 2019, CLInical Monitoring and Biomarkers to stratify severity and predict outcomes in children with cystic fibrosis (CLIMB-CF): results from the feasibility study, J Cyst Fibros, 18, S52, 10.1016/S1569-1993(19)30285-1 · DOI
Cited by
Sorted by citations
Dawson, S., Girling, C.-J., Cowap, L., & Clark-Carter, D. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013766.pub2 · Cited by 14
Metadata
- Authors
- Hoo, Z. H., & Wildman, M. J.
- Affiliations
- Northern General Hospital (GB)
- Corresponding author
- Hoo, Zhe Hui
- Wildman, Martin J
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 19
- Issue
- 2
- Pages
- e9
- ISSN
- 1569-1993 (ISSN-L)
- OpenAlex
- W2982573304
- Cited by
- 2
- References
- 3
- Citations by year
- 2023: 2
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Cystic Fibrosis (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- National Institute for Health and Care Research (DRF-2014-07-092)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- exacerbation detection, mobile application, symptom monitoring, adults
- MeSH terms
- Smartphone, Adult, Cystic Fibrosis, Forced Expiratory Volume, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
